CTRI/2024/07/069955尚未招募2 期
Evaluation and comparison of patient reported outcome measures and anti-plaque effectiveness of a novel herbal chewing gum containing neem extracts with placebo chewing gum: A double blind crossover clinical trial. - NI
Ranjeet Deshmukh Dental College and Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients agreeing to comply with study protocol and instructions
- •2. Patients in good health in age range of 18-45 years.
- •3. Subject should have at least 20 natural permanent teeth in dentition
- •4. Periodontal pockets not greater than 3mm.
- •5. All subjects who are deemed medically fit.
- •6. Subjects having Gingival index score not more than 1.9.
- •7. Subjects who had a plaque index of greater than 2 at baseline.
排除标准
- •Smokers and tobacco chewer
- •2. Patients with systemic diseases or compromising medical condition.
- •3. Patients on antibiotics one months prior to treatment.
- •4. Patients using orthodontic appliances either fixed or removable
- •5. Patients who have been using any mouth rinse containing chemical agents in previous 3 months.
- •6. Patients allergic or sensitive to any medication.
- •7. History of any surgical procedure in the selected area in the past six months.
- •8. Pregnant and lactating women, smokers, acute myocardial infarction within the past 6 months, use of pacemaker and uncontrolled metabolic diseases.
研究者
相似试验
尚未招募
不适用
Comparison of collecting patient-reported outcome measurements between electronic-based and paper-based questionnaire in adults with low back pain: a randomized controlled crossover trialow back painLow back painTCTR20190814001Faculty of Medicine, Naresuan university246
进行中（未招募）
不适用
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution - DuoTrav APS versus XALACOM® in Patient Reported Outcomes and Ocular Surface HealthEUCTR2009-010604-29-BEAlcon Research, Ltd.400
已完成
3 期
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution.raised intra-ocular pressure with optic nerve damageraised intra-ocular pressure without optic nerve damage10018307NL-OMON35130Alcon Laboratories30
进行中（未招募）
不适用
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using Travoprost APS Eye Drops Solution Versus XALATAN Eye Drops Solution - Travoprost APS versus XALATAN in OSDIOpen Angle Glaucoma or Ocular HypertensionMedDRA version: 9.1Level: LLTClassification code 10030043Term: Ocular hypertensionMedDRA version: 9.1Level: LLTClassification code 10030348Term: Open angle glaucomaEUCTR2009-010606-10-GBAlcon Research, Ltd.516
进行中（未招募）
不适用
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution - DuoTrav APS versus XALACOM® in Patient Reported Outcomes and Ocular Surface Healthglaucoma/dry eyeMedDRA version: 9.1Level: LLTClassification code 10030348Term: Open angle glaucomaMedDRA version: 9.1Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionMedDRA version: 9.1Level: LLTClassification code 10030043Term: Ocular hypertensionMedDRA version: 9.1Level: LLTClassification code 10013774Term: Dry eyeEUCTR2009-010604-29-PTAlcon Research, Ltd.400